ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urapidil Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7A6039
Home | Market Reports | Health| Nursing
Global Urapidil Market Insights and Forecast to 2028
BUY CHAPTERS

Global Urapidil Market Research Report 2025

Code: QYRE-Auto-7A6039
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Sanwa Kagaku Kenkyusho
AbbVie
Kaken Pharm
Abbott
Huayu (Wuxi) Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Wanzheng Pharmaceutical
Hebei Yipin Pharmaceutical
Xi'an Lijun Pharmaceutical
Tonghua Jinma Pharmaceutical Group
Changchun Tiancheng Pharmaceutical
Heilongjiang fuhe Pharmaceutical Group

Urapidil Market

The global market for Urapidil was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Urapidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Urapidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Urapidil in Severe Hypertension And Refractory Hypertension is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Urapidil include Takeda, Sanwa Kagaku Kenkyusho, AbbVie, Kaken Pharm, Abbott, Huayu (Wuxi) Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Guangzhou Wanzheng Pharmaceutical, Hebei Yipin Pharmaceutical, Xi'an Lijun Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urapidil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urapidil.
The Urapidil market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urapidil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urapidil companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Urapidil Market Report

Report Metric Details
Report Name Urapidil Market
Segment by Type
  • Injection
  • Tablets
Segment by Application
  • Severe Hypertension And Refractory Hypertension
  • Control Perioperative Hypertension
  • Essential Hypertension
  • Renal Hypertension
  • High Blood Pressure Caused By Pheochromocytoma
  • Congestive Heart Failure
  • Dysuria
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Sanwa Kagaku Kenkyusho, AbbVie, Kaken Pharm, Abbott, Huayu (Wuxi) Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Guangzhou Wanzheng Pharmaceutical, Hebei Yipin Pharmaceutical, Xi'an Lijun Pharmaceutical, Tonghua Jinma Pharmaceutical Group, Changchun Tiancheng Pharmaceutical, Heilongjiang Fuhe Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Urapidil company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urapidil Market report?

Ans: The main players in the Urapidil Market are Takeda, Sanwa Kagaku Kenkyusho, AbbVie, Kaken Pharm, Abbott, Huayu (Wuxi) Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Guangzhou Wanzheng Pharmaceutical, Hebei Yipin Pharmaceutical, Xi'an Lijun Pharmaceutical, Tonghua Jinma Pharmaceutical Group, Changchun Tiancheng Pharmaceutical, Heilongjiang Fuhe Pharmaceutical Group

What are the Application segmentation covered in the Urapidil Market report?

Ans: The Applications covered in the Urapidil Market report are Severe Hypertension And Refractory Hypertension, Control Perioperative Hypertension, Essential Hypertension, Renal Hypertension, High Blood Pressure Caused By Pheochromocytoma, Congestive Heart Failure, Dysuria, Other

What are the Type segmentation covered in the Urapidil Market report?

Ans: The Types covered in the Urapidil Market report are Injection, Tablets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urapidil Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Urapidil Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Severe Hypertension And Refractory Hypertension
1.3.3 Control Perioperative Hypertension
1.3.4 Essential Hypertension
1.3.5 Renal Hypertension
1.3.6 High Blood Pressure Caused By Pheochromocytoma
1.3.7 Congestive Heart Failure
1.3.8 Dysuria
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urapidil Market Perspective (2020-2031)
2.2 Global Urapidil Growth Trends by Region
2.2.1 Global Urapidil Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Urapidil Historic Market Size by Region (2020-2025)
2.2.3 Urapidil Forecasted Market Size by Region (2026-2031)
2.3 Urapidil Market Dynamics
2.3.1 Urapidil Industry Trends
2.3.2 Urapidil Market Drivers
2.3.3 Urapidil Market Challenges
2.3.4 Urapidil Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urapidil Players by Revenue
3.1.1 Global Top Urapidil Players by Revenue (2020-2025)
3.1.2 Global Urapidil Revenue Market Share by Players (2020-2025)
3.2 Global Urapidil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Urapidil Revenue
3.4 Global Urapidil Market Concentration Ratio
3.4.1 Global Urapidil Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urapidil Revenue in 2024
3.5 Global Key Players of Urapidil Head office and Area Served
3.6 Global Key Players of Urapidil, Product and Application
3.7 Global Key Players of Urapidil, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urapidil Breakdown Data by Type
4.1 Global Urapidil Historic Market Size by Type (2020-2025)
4.2 Global Urapidil Forecasted Market Size by Type (2026-2031)
5 Urapidil Breakdown Data by Application
5.1 Global Urapidil Historic Market Size by Application (2020-2025)
5.2 Global Urapidil Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Urapidil Market Size (2020-2031)
6.2 North America Urapidil Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Urapidil Market Size by Country (2020-2025)
6.4 North America Urapidil Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urapidil Market Size (2020-2031)
7.2 Europe Urapidil Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Urapidil Market Size by Country (2020-2025)
7.4 Europe Urapidil Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urapidil Market Size (2020-2031)
8.2 Asia-Pacific Urapidil Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Urapidil Market Size by Region (2020-2025)
8.4 Asia-Pacific Urapidil Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urapidil Market Size (2020-2031)
9.2 Latin America Urapidil Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Urapidil Market Size by Country (2020-2025)
9.4 Latin America Urapidil Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urapidil Market Size (2020-2031)
10.2 Middle East & Africa Urapidil Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Urapidil Market Size by Country (2020-2025)
10.4 Middle East & Africa Urapidil Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Urapidil Introduction
11.1.4 Takeda Revenue in Urapidil Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 Sanwa Kagaku Kenkyusho
11.2.1 Sanwa Kagaku Kenkyusho Company Details
11.2.2 Sanwa Kagaku Kenkyusho Business Overview
11.2.3 Sanwa Kagaku Kenkyusho Urapidil Introduction
11.2.4 Sanwa Kagaku Kenkyusho Revenue in Urapidil Business (2020-2025)
11.2.5 Sanwa Kagaku Kenkyusho Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Urapidil Introduction
11.3.4 AbbVie Revenue in Urapidil Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Kaken Pharm
11.4.1 Kaken Pharm Company Details
11.4.2 Kaken Pharm Business Overview
11.4.3 Kaken Pharm Urapidil Introduction
11.4.4 Kaken Pharm Revenue in Urapidil Business (2020-2025)
11.4.5 Kaken Pharm Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Urapidil Introduction
11.5.4 Abbott Revenue in Urapidil Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Huayu (Wuxi) Pharmaceutical
11.6.1 Huayu (Wuxi) Pharmaceutical Company Details
11.6.2 Huayu (Wuxi) Pharmaceutical Business Overview
11.6.3 Huayu (Wuxi) Pharmaceutical Urapidil Introduction
11.6.4 Huayu (Wuxi) Pharmaceutical Revenue in Urapidil Business (2020-2025)
11.6.5 Huayu (Wuxi) Pharmaceutical Recent Development
11.7 Shandong Luoxin Pharmaceutical Group
11.7.1 Shandong Luoxin Pharmaceutical Group Company Details
11.7.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.7.3 Shandong Luoxin Pharmaceutical Group Urapidil Introduction
11.7.4 Shandong Luoxin Pharmaceutical Group Revenue in Urapidil Business (2020-2025)
11.7.5 Shandong Luoxin Pharmaceutical Group Recent Development
11.8 Guangzhou Wanzheng Pharmaceutical
11.8.1 Guangzhou Wanzheng Pharmaceutical Company Details
11.8.2 Guangzhou Wanzheng Pharmaceutical Business Overview
11.8.3 Guangzhou Wanzheng Pharmaceutical Urapidil Introduction
11.8.4 Guangzhou Wanzheng Pharmaceutical Revenue in Urapidil Business (2020-2025)
11.8.5 Guangzhou Wanzheng Pharmaceutical Recent Development
11.9 Hebei Yipin Pharmaceutical
11.9.1 Hebei Yipin Pharmaceutical Company Details
11.9.2 Hebei Yipin Pharmaceutical Business Overview
11.9.3 Hebei Yipin Pharmaceutical Urapidil Introduction
11.9.4 Hebei Yipin Pharmaceutical Revenue in Urapidil Business (2020-2025)
11.9.5 Hebei Yipin Pharmaceutical Recent Development
11.10 Xi'an Lijun Pharmaceutical
11.10.1 Xi'an Lijun Pharmaceutical Company Details
11.10.2 Xi'an Lijun Pharmaceutical Business Overview
11.10.3 Xi'an Lijun Pharmaceutical Urapidil Introduction
11.10.4 Xi'an Lijun Pharmaceutical Revenue in Urapidil Business (2020-2025)
11.10.5 Xi'an Lijun Pharmaceutical Recent Development
11.11 Tonghua Jinma Pharmaceutical Group
11.11.1 Tonghua Jinma Pharmaceutical Group Company Details
11.11.2 Tonghua Jinma Pharmaceutical Group Business Overview
11.11.3 Tonghua Jinma Pharmaceutical Group Urapidil Introduction
11.11.4 Tonghua Jinma Pharmaceutical Group Revenue in Urapidil Business (2020-2025)
11.11.5 Tonghua Jinma Pharmaceutical Group Recent Development
11.12 Changchun Tiancheng Pharmaceutical
11.12.1 Changchun Tiancheng Pharmaceutical Company Details
11.12.2 Changchun Tiancheng Pharmaceutical Business Overview
11.12.3 Changchun Tiancheng Pharmaceutical Urapidil Introduction
11.12.4 Changchun Tiancheng Pharmaceutical Revenue in Urapidil Business (2020-2025)
11.12.5 Changchun Tiancheng Pharmaceutical Recent Development
11.13 Heilongjiang Fuhe Pharmaceutical Group
11.13.1 Heilongjiang Fuhe Pharmaceutical Group Company Details
11.13.2 Heilongjiang Fuhe Pharmaceutical Group Business Overview
11.13.3 Heilongjiang Fuhe Pharmaceutical Group Urapidil Introduction
11.13.4 Heilongjiang Fuhe Pharmaceutical Group Revenue in Urapidil Business (2020-2025)
11.13.5 Heilongjiang Fuhe Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Takeda
Sanwa Kagaku Kenkyusho
AbbVie
Kaken Pharm
Abbott
Huayu (Wuxi) Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Wanzheng Pharmaceutical
Hebei Yipin Pharmaceutical
Xi'an Lijun Pharmaceutical
Tonghua Jinma Pharmaceutical Group
Changchun Tiancheng Pharmaceutical
Heilongjiang fuhe Pharmaceutical Group
List of Tables
 Table 1. Global Urapidil Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection
 Table 3. Key Players of Tablets
 Table 4. Global Urapidil Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Urapidil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Urapidil Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Urapidil Market Share by Region (2020-2025)
 Table 8. Global Urapidil Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Urapidil Market Share by Region (2026-2031)
 Table 10. Urapidil Market Trends
 Table 11. Urapidil Market Drivers
 Table 12. Urapidil Market Challenges
 Table 13. Urapidil Market Restraints
 Table 14. Global Urapidil Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Urapidil Market Share by Players (2020-2025)
 Table 16. Global Top Urapidil Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urapidil as of 2024)
 Table 17. Ranking of Global Top Urapidil Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Urapidil Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Urapidil, Headquarters and Area Served
 Table 20. Global Key Players of Urapidil, Product and Application
 Table 21. Global Key Players of Urapidil, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Urapidil Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Urapidil Revenue Market Share by Type (2020-2025)
 Table 25. Global Urapidil Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Urapidil Revenue Market Share by Type (2026-2031)
 Table 27. Global Urapidil Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Urapidil Revenue Market Share by Application (2020-2025)
 Table 29. Global Urapidil Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Urapidil Revenue Market Share by Application (2026-2031)
 Table 31. North America Urapidil Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Urapidil Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Urapidil Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Urapidil Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Urapidil Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Urapidil Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Urapidil Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Urapidil Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Urapidil Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Urapidil Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Urapidil Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Urapidil Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Urapidil Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Urapidil Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Urapidil Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Takeda Company Details
 Table 47. Takeda Business Overview
 Table 48. Takeda Urapidil Product
 Table 49. Takeda Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 50. Takeda Recent Development
 Table 51. Sanwa Kagaku Kenkyusho Company Details
 Table 52. Sanwa Kagaku Kenkyusho Business Overview
 Table 53. Sanwa Kagaku Kenkyusho Urapidil Product
 Table 54. Sanwa Kagaku Kenkyusho Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 55. Sanwa Kagaku Kenkyusho Recent Development
 Table 56. AbbVie Company Details
 Table 57. AbbVie Business Overview
 Table 58. AbbVie Urapidil Product
 Table 59. AbbVie Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 60. AbbVie Recent Development
 Table 61. Kaken Pharm Company Details
 Table 62. Kaken Pharm Business Overview
 Table 63. Kaken Pharm Urapidil Product
 Table 64. Kaken Pharm Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 65. Kaken Pharm Recent Development
 Table 66. Abbott Company Details
 Table 67. Abbott Business Overview
 Table 68. Abbott Urapidil Product
 Table 69. Abbott Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 70. Abbott Recent Development
 Table 71. Huayu (Wuxi) Pharmaceutical Company Details
 Table 72. Huayu (Wuxi) Pharmaceutical Business Overview
 Table 73. Huayu (Wuxi) Pharmaceutical Urapidil Product
 Table 74. Huayu (Wuxi) Pharmaceutical Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 75. Huayu (Wuxi) Pharmaceutical Recent Development
 Table 76. Shandong Luoxin Pharmaceutical Group Company Details
 Table 77. Shandong Luoxin Pharmaceutical Group Business Overview
 Table 78. Shandong Luoxin Pharmaceutical Group Urapidil Product
 Table 79. Shandong Luoxin Pharmaceutical Group Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 80. Shandong Luoxin Pharmaceutical Group Recent Development
 Table 81. Guangzhou Wanzheng Pharmaceutical Company Details
 Table 82. Guangzhou Wanzheng Pharmaceutical Business Overview
 Table 83. Guangzhou Wanzheng Pharmaceutical Urapidil Product
 Table 84. Guangzhou Wanzheng Pharmaceutical Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 85. Guangzhou Wanzheng Pharmaceutical Recent Development
 Table 86. Hebei Yipin Pharmaceutical Company Details
 Table 87. Hebei Yipin Pharmaceutical Business Overview
 Table 88. Hebei Yipin Pharmaceutical Urapidil Product
 Table 89. Hebei Yipin Pharmaceutical Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 90. Hebei Yipin Pharmaceutical Recent Development
 Table 91. Xi'an Lijun Pharmaceutical Company Details
 Table 92. Xi'an Lijun Pharmaceutical Business Overview
 Table 93. Xi'an Lijun Pharmaceutical Urapidil Product
 Table 94. Xi'an Lijun Pharmaceutical Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 95. Xi'an Lijun Pharmaceutical Recent Development
 Table 96. Tonghua Jinma Pharmaceutical Group Company Details
 Table 97. Tonghua Jinma Pharmaceutical Group Business Overview
 Table 98. Tonghua Jinma Pharmaceutical Group Urapidil Product
 Table 99. Tonghua Jinma Pharmaceutical Group Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 100. Tonghua Jinma Pharmaceutical Group Recent Development
 Table 101. Changchun Tiancheng Pharmaceutical Company Details
 Table 102. Changchun Tiancheng Pharmaceutical Business Overview
 Table 103. Changchun Tiancheng Pharmaceutical Urapidil Product
 Table 104. Changchun Tiancheng Pharmaceutical Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 105. Changchun Tiancheng Pharmaceutical Recent Development
 Table 106. Heilongjiang Fuhe Pharmaceutical Group Company Details
 Table 107. Heilongjiang Fuhe Pharmaceutical Group Business Overview
 Table 108. Heilongjiang Fuhe Pharmaceutical Group Urapidil Product
 Table 109. Heilongjiang Fuhe Pharmaceutical Group Revenue in Urapidil Business (2020-2025) & (US$ Million)
 Table 110. Heilongjiang Fuhe Pharmaceutical Group Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Urapidil Picture
 Figure 2. Global Urapidil Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Urapidil Market Share by Type: 2024 VS 2031
 Figure 4. Injection Features
 Figure 5. Tablets Features
 Figure 6. Global Urapidil Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Urapidil Market Share by Application: 2024 VS 2031
 Figure 8. Severe Hypertension And Refractory Hypertension Case Studies
 Figure 9. Control Perioperative Hypertension Case Studies
 Figure 10. Essential Hypertension Case Studies
 Figure 11. Renal Hypertension Case Studies
 Figure 12. High Blood Pressure Caused By Pheochromocytoma Case Studies
 Figure 13. Congestive Heart Failure Case Studies
 Figure 14. Dysuria Case Studies
 Figure 15. Other Case Studies
 Figure 16. Urapidil Report Years Considered
 Figure 17. Global Urapidil Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Urapidil Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Urapidil Market Share by Region: 2024 VS 2031
 Figure 20. Global Urapidil Market Share by Players in 2024
 Figure 21. Global Top Urapidil Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urapidil as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Urapidil Revenue in 2024
 Figure 23. North America Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Urapidil Market Share by Country (2020-2031)
 Figure 25. United States Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Urapidil Market Share by Country (2020-2031)
 Figure 29. Germany Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Urapidil Market Share by Region (2020-2031)
 Figure 37. China Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Urapidil Market Share by Country (2020-2031)
 Figure 45. Mexico Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Urapidil Market Share by Country (2020-2031)
 Figure 49. Turkey Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Urapidil Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Takeda Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 53. Sanwa Kagaku Kenkyusho Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 54. AbbVie Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 55. Kaken Pharm Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 56. Abbott Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 57. Huayu (Wuxi) Pharmaceutical Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 58. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 59. Guangzhou Wanzheng Pharmaceutical Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 60. Hebei Yipin Pharmaceutical Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 61. Xi'an Lijun Pharmaceutical Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 62. Tonghua Jinma Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 63. Changchun Tiancheng Pharmaceutical Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 64. Heilongjiang Fuhe Pharmaceutical Group Revenue Growth Rate in Urapidil Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Urapidil Hydrochloride Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urapidil Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Upadacitinib API Market Research Report 2024
Global Olaparib Market Research Report 2024
Global Uric Acid Market Research Report 2024
Global Naftopidil Market Research Report 2025
Global Palbociclib Market Research Report 2024
Global Apatinib Market Research Report 2024
Global Niraparib Market Research Report 2024
Global Aripiprazole Market Research Report 2025
Global Imidapril Market Research Report 2024
Global Lacidipine Market Research Report 2024
Global Uracil Market Research Report 2025
Global Cefdinir API Market Research Report 2025
Global Sulpiride Market Research Report 2025
Cimetidine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Minoxidil API Market Research Report 2025
Global Rilpivirine Market Research Report 2024
Global Ceritinib Market Research Report 2024
Global Ropidoxuridine IPdR Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions